Evidence map›Paper›PMID 40732343›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations.

Saltanat Nakypova, Andrey Smolobochkin, Tanzilya Rizbayeva, Rakhymzhan Turmanov, Almir Gazizov, Nurgali Akylbekov, Rakhmetulla Zhapparbergenov, Roza Narmanova, Saltanat Ibadullayeva, Alena Zalaltdinova and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Saltanat NakypovaFaculty of Chemistry and Chemical Technology, Al Farabi Kazakh National University, Al-Farabi Avenue 71, Almaty 050040, Kazakhstan.
Andrey SmolobochkinArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0002-1470-8136
Tanzilya RizbayevaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0003-2326-516X
Rakhymzhan TurmanovDepartment of Chemistry, Abai Kazakh National Pedagogical University, Dostyk Avenue 13, Almaty 050010, Kazakhstan.
Almir GazizovArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0001-9899-9606
Nurgali AkylbekovLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, Aiteke Bi Street 29A, Kyzylorda 120014, Kazakhstan.ORCID 0000-0002-7584-9741
Rakhmetulla ZhapparbergenovLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, Aiteke Bi Street 29A, Kyzylorda 120014, Kazakhstan.
Roza NarmanovaLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, Aiteke Bi Street 29A, Kyzylorda 120014, Kazakhstan.ORCID 0000-0001-5672-7418
Saltanat IbadullayevaLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, Aiteke Bi Street 29A, Kyzylorda 120014, Kazakhstan.
Alena ZalaltdinovaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0002-4822-7330
Marat SyzdykbayevLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, Aiteke Bi Street 29A, Kyzylorda 120014, Kazakhstan.
Julia VoroninaN.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Leninskii Avenue 31, Moscow 119991, Russia.ORCID 0000-0001-9222-5853
Anna LyubinaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0002-2816-8142
Alexandra VoloshinaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.ORCID 0000-0002-3540-8554
Elena KlimanovaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, Russia.
Tatiana SashenkovaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, Russia.
Denis MishchenkoFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Avenue 1, Chernogolovka 142432, Russia.ORCID 0000-0003-3779-3211
Alexander BurilovArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Academician Arbuzov Street 8, Kazan 420088, Russia.

Funding

Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP23487716
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancer agentsaza-Michael reactionpyrrolidinetaurine

Identifiers

PMID40732343
PMCPMC12300679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.